{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:56:21Z","timestamp":1786409781076,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.jpeds.2009.07.006","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T05:05:20Z","timestamp":1253163920000},"page":"S47-S56","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S","title":["The Brazilian Consensus on the Management of Pompe Disease"],"prefix":"10.1016","volume":"155","author":[{"suffix":"Jr.","given":"Juan C.","family":"Llerena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne Maria","family":"Horovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely Kazue","family":"Nagahashi Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Porta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giugliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ver\u00f3nica","family":"Mu\u00f1oz Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2009.07.006_bib1","unstructured":"Online Mendelian Inheritance in Man (OMIM). Available from: http:\/\/www.ncbi.nlm.nih.gov\/omim. Accessed July 30, 2008."},{"key":"10.1016\/j.jpeds.2009.07.006_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.jpeds.2009.07.006_bib3","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.07.006_bib4","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib5","first-page":"83","article-title":"A retrospective epidemiological and etiological study of metabolic disorders in children with cardiomypathies","volume":"47","author":"Wang","year":"2006","journal-title":"Acta Paediatr Taiwan"},{"key":"10.1016\/j.jpeds.2009.07.006_bib6","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.spen.2006.06.007","article-title":"Glycogen storage disease: clinical, biochemical, and molecular heterogeneity","volume":"13","author":"Shin","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"A retrospective multinational, multicenter study of the natural history of infantile Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.07.006_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.gim.0000204462.42910.b8","article-title":"Diagnostic challenges for Pompe disease: an underrecognized cause of floppy baby syndrome","volume":"8","author":"Howell","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guidelines","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00247-007-0428-y","article-title":"Fractures in children with Pompe disease: a potential long-term complication","volume":"37","author":"Case","year":"2007","journal-title":"Pediatr Radiol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/01.gim.0000217786.79173.a8","article-title":"Ambulatory electrocardiogram analysis in infants treated with recombinant human acid-glucosidase enzyme replacement therapy for Pompe disease","volume":"8","author":"Cook","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid alpha-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.GIM.0000154301.76619.5C","article-title":"Infantile-onset Pompe disease: a report of physician narratives from an epidemiologic study","volume":"7","author":"Marsden","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.gim.0000195896.04069.5f","article-title":"Electrocardiographic response to enzyme replacement therapy for Pompe disease","volume":"8","author":"Ansong","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib15","first-page":"651","article-title":"Percentile curves of normal values of echocardiographic measurements in normal children from the central-southern region of the state of S\u00e3o Paulo, Brazil","volume":"87","author":"Bonatto","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00431-006-0315-9","article-title":"Isolated elevated serum transaminases leading to the diagnosis of asymptomatic Pompe disease","volume":"166","author":"Hoeksma","year":"2007","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2009.07.006_bib17","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.wnl.0000216144.69630.6e","article-title":"Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia","volume":"66","author":"Fernandez","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib18","first-page":"1","article-title":"Clinical manifestations and natural course of late-onset Pompe's disease in 54 Dutch patients","author":"Hagemans","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jpeds.2009.07.006_bib19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease: a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00415-006-0434-2","article-title":"Fatigue: an important feature of late-onset Pompe disease","volume":"254","author":"Hagemans","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.nmd.2006.02.001","article-title":"Juvenile-onset acid maltase deficiency presenting as a rigid spine syndrome","volume":"16","author":"Pruszczyk","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2009.07.006_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2007.03.006","article-title":"Impact of late-onset Pompe disease on participation in daily life activities: evaluation of the Rotterdam Handicap Scale","author":"Hagemans","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2009.07.006_bib23","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jpeds.2009.07.006_bib24","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/01.wnl.0000198776.53007.2c","article-title":"Course of disability and respiratory function in untreated late-onset Pompe disease","volume":"66","author":"Hagemans","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1399-0004.2005.00557.x","article-title":"Two clinical forms of glycogen-storage disease type II in two generations of the same family","volume":"69","author":"Amartino","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.jpeds.2009.07.006_bib26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2009.07.006_bib27","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-009-5219-y","article-title":"Pompe disease in a Brazilian series: clinical and molecular analysis with identification of nine new mutations","author":"Oba-Shinjo","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nmd.2006.09.004","article-title":"Pompe disease (glycogen storage disease type II) in Argentineans: clinical manifestations and identification of 9 novel mutations","volume":"1","author":"Palmer","year":"2007","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2009.07.006_bib29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1212\/01.wnl.0000252798.25690.76","article-title":"Broad spectrum of Pompe disease in patients with the same c.-32-13T-G haplotype","volume":"68","author":"Kroos","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib30","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jns.2006.09.012","article-title":"Two new missense mutations of GAA in late onset glycogen storage disease type II","volume":"251","author":"Park","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jpeds.2009.07.006_bib31","first-page":"8307","article-title":"The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease","author":"Jack","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10545-006-0265-4","article-title":"Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders","volume":"29","author":"Gelb","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2009.07.006_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid \u03b1-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib34","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by Xuorometric assay of \u03b1-glucosidase activities in dried blood spots","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2009.07.006_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ymgme.2007.09.006","article-title":"Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting","volume":"93","author":"Winchester","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jpeds.2009.07.006_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ab.2005.06.042","article-title":"Profiling oligosaccharidurias by electrospray tandem mass spectrometry: quantifying reducing oligosaccharides","volume":"345","author":"Ramsay","year":"2005","journal-title":"Anal Biochem"},{"key":"10.1016\/j.jpeds.2009.07.006_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cccn.2005.05.025","article-title":"Correlation of acid a-glucosidase and glycogen content in skin fibroblasts with age of onset in Pompe disease","volume":"361","author":"Umapathysivam","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2009.07.006_bib38","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.jpeds.2009.07.006_bib39","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/ana.20019","article-title":"Enzyme replacement therapy in late-onset Pompe's disease: a three-year follow-up","volume":"55","author":"Winkel","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/j.1540-8159.1999.tb00551.x","article-title":"An interesting case of infant sudden death: severe hypertrophic cardiomyopathy in Pompe's disease","volume":"22","author":"Metzl","year":"1999","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jpeds.2009.07.006_bib41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1460-9592.2004.01242.x","article-title":"Anaesthetic management of infants with glycogen storage disease type II: a physiological approach","volume":"14","author":"Ing","year":"2004","journal-title":"Pediatr Anesth"},{"key":"10.1016\/j.jpeds.2009.07.006_bib42","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.jpeds.2009.07.006_bib43","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1007\/PL00014270","article-title":"Dietary treatment in late-onset acid maltase deficiency","volume":"156","author":"Bodamer","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jpeds.2009.07.006_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10545-006-0238-7","article-title":"The effect of L-alanine therapy in a patient with adult-onset glycogen storage disease type II","volume":"29","author":"Mundy","year":"2006","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2009.07.006_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/mus.10381","article-title":"Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy","volume":"27","author":"Winkel","year":"2003","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jpeds.2009.07.006_bib46","first-page":"82","article-title":"Pompe disease (glycogen storage disease type II): clinical features and enzyme replacement therapy","volume":"106","author":"Beek","year":"2006","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jpeds.2009.07.006_bib47","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab Invest"},{"key":"10.1016\/j.jpeds.2009.07.006_bib48","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/01.wnl.0000253226.13795.40","article-title":"Enzyme replacement for infantile Pompe disease: the first step toward a cure","volume":"68","author":"Wagner","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jpeds.2009.07.006_bib49","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bbrc.2006.09.133","article-title":"Hyaluronidase increases the biodistribution of acid a-1,4 glucosidase in the muscle of Pompe disease mice: an approach to enhance the efficacy of enzyme replacement therapy","volume":"359","author":"Matalon","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jpeds.2009.07.006_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(00)02533-2","article-title":"Recombinant human alpha-glucosidase from rabbit milk in Pompe patients","volume":"356","author":"Van den Hout","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jpeds.2009.07.006_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2009.07.006_bib52","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib53","first-page":"77","article-title":"Long-term efficacy of enzyme replacement therapy (ERT) in children with Pompe disease","volume":"146","author":"Kishnani","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2009.07.006_bib54","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2009.07.006_bib55","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase OO clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.jpeds.2009.07.006_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Results from a phase II trial of Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease","author":"Kishnani","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2009.07.006_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000080776","article-title":"ECLAMC: the Latin-American Collaborative Study of Congenital Malformations","volume":"7","author":"Castilla","year":"2004","journal-title":"Community Genet"},{"key":"10.1016\/j.jpeds.2009.07.006_bib58","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10545-006-0427-4","article-title":"Sudden deterioration in nonclassical infantile-onset Pompe disease responding to alglucosidase alfa infusion therapy: a case report","volume":"29","author":"Pascual-Pascual","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jpeds.2009.07.006_bib59","series-title":"Novas Tecnologias na Gen\u00e9tica Humana: Avan\u00e7os e Impactos para a Sa\u00fade","first-page":"81","article-title":"Doen\u00e7as gen\u00e9ticas: desafio para o SUS","author":"Llerena","year":"2007"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609006763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347609006763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,16]],"date-time":"2018-12-16T18:53:01Z","timestamp":1544986381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347609006763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0022347609006763"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2009.07.006","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}